Expert consensus on the colorectal cancer annotation of CT and MRI (2020) (translation)
Tóm tắt
Colorectal cancer is one of the most common clinical malignancies. The application of artificial intelligence to colorectal cancer can help to detect and diagnose lesions, evaluate curative effects and prognosis, and conduct follow-up, so as to benefit patients. To standardize the marking of colorectal cancer data and promote the better implementation of artificial intelligence in clinical practice, Image Big Data Artificial Intelligence Working Committee of Chinese Society of Radiology Chinese Medical Association, Abdominal Group of Chinese Society of Radiology Chinese Medical Association, and Magnetic Resonance Imaging Group of Chinese Society of Radiology Chinese Medical Association jointly compiled an expert consensus on CT and MRI annotation for colorectal cancer. Expert consensus involves the definition and imaging manifestations of colorectal cancer, labeling categories and methods, precautions, labeling principles, labeling requirements, labeling personnel requirements and procedures, etc. This helps to improve the consistency of data annotation, establish an artificial intelligence algorithm model with good robustness and strong generalization ability, and improve the level of colorectal cancer diagnosis and treatment.
Tài liệu tham khảo
Image Big Data Artificial Intelligence Working Committee of Chinese Society of Radiology Chinese Medical Association, Abdominal Group of Chinese Society of Radiology Chinese Medical Association, Magnetic Resonance Imaging Group of Chinese Society of Radiology Chinese Medical Association. Expert consensus on the colorectal cancer annotation of CT and MRI. Chin J Radiol. 2020;55(2):111–6.
National Health Commission of the People’s Republic of China. Chinese protocol of diagnosis and treatment of colorectal cancer. Chin J Surg. 2020;58(8):561–85. https://doi.org/10.3760/cma.j.cn112139‑20200518‑00390.
Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl4):iv263. https://doi.org/10.1093/annonc/mdy161.
Chen XP, Wang JP. Surgery. 8th ed. Beijing: People’s Medical Publishing House; 2013. p. 402–7.
Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med. 2008;359(12):1207–17. https://doi.org/10.1056/NEJMoa0800996.
Hyngstrom JR, Hu CY, Xing Y, et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012;19(9):2814–21. https://doi.org/10.1245/s10434-012-2321-7.
Shi L, Zhang Y, Nie K, et al. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI. Magn Reson Imaging. 2019;61:33–40. https://doi.org/10.1016/j.mri.2019.05.003.
Horvat N, Veeraraghavan H, Khan M, et al. MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology. 2018;287(3):833–43. https://doi.org/10.1148/radiol.2018172300.
Liu Z, Zhang XY, Shi YJ, et al. Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clin Cancer Res. 2017;23(23):7253–62. https://doi.org/10.1158/1078-0432.CCR-17-1038.
Tang Z, Zhang XY, Liu Z, et al. Quantitative analysis of diffusion weighted imaging to predict pathological good response to neoadjuvant chemoradiation for locally advanced rectal cancer. Radiother Oncol. 2019;132:100–8. https://doi.org/10.1016/j.radonc.2018.11.007.
Zhang XY, Wang L, Zhu HT, et al. Predicting rectal cancer response to neoadjuvant chemoradiotherapy using deep learning of diffusion kurtosis MRI. Radiology. 2020;296(1):56–64. https://doi.org/10.1148/radiol.2020190936.
Huang Z, Zhang W, He D, et al. Development and validation of a radiomics model based on T2WI images for preoperative prediction of microsatellite instability status in rectal cancer: Study Protocol Clinical Trial (SPIRIT Compliant). Medicine (Baltimore). 2020;99(10): e19428. https://doi.org/10.1097/MD.0000000000019428.
Chen J, Chen Y, Zheng D, et al. Pretreatment MR-based radiomics signature as potential imaging biomarker for assessing the expression of topoisomerase II alpha (TOPO-IIα) in rectal cancer. J Magn Reson Imaging. 2020;51(6):1881–9. https://doi.org/10.1002/jmri.26972.
Shu Z, Fang S, Ding Z, et al. MRI-based radiomics nomogram to detect primary rectal cancer with synchronous liver metastases. Sci Rep. 2019;9(1):3374. https://doi.org/10.1038/s41598-019-39651-y.
Trebeschi S, van Griethuysen J, Lambregts D, et al. Author correction: deep learning for fully-automated localization and segmentation of rectal cancer on multiparametric MR. Sci Rep. 2018;8(1):2589. https://doi.org/10.1038/s41598-018-20029-5.
Antunes JT, Ofshteyn A, Bera K, et al. Radiomic features of primary rectal cancers on baseline T2-weighted MRI are associated with pathologic complete response to neoadjuvant chemoradiation: a multisite study. J Magn Reson Imaging. 2020;52(5):1531–41. https://doi.org/10.1002/jmri.27140.
Cui Y, Liu H, Ren J, et al. Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer. Eur Radiol. 2020;30(4):1948–58. https://doi.org/10.1007/s00330-019-06572-3.
Zhang C, Ding ZH, Yu J, et al. Anatomic observation of annular distribution of perirectal fascia and space around the mesorectum. Chin J Gastrointest Surg. 2011;14(11):882–6. https://doi.org/10.3760/cma.j.issn.1671-0274.2011.11.017.
National Institutes for Food and Drug Control, Cardio⁃thoracic Working Group, Chinese Society of Radiology,Chinese Medical Association. Expert consensus on the rule and quality control of pulmonary nodule annotation based on thoracic CT (2018 edition). Chin J Radiol. 2019;53(1):9–15. https://doi.org/10.3760/cma.j.issn.1005‑1201.2019.01.004.